Skip to main navigation Skip to search Skip to main content

Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity

  • Carlos M.G. Azevedo
  • , Kenneth R. Watterson
  • , Ed T. Wargent
  • , Steffen V.F. Hansen
  • , Brian D. Hudson
  • , Małgorzata A. Kȩpczyńska
  • , Julia Dunlop
  • , Bharat Shimpukade
  • , Elisabeth Christiansen
  • , Graeme Milligan
  • , Claire J. Stocker
  • , Trond Ulven*
  • *Corresponding author for this work
    • University of Southern Denmark
    • University of Glasgow
    • University of Buckingham

    Research output: Contribution to journal › Article › peer-review

    Abstract

    The free fatty acid receptor 4 (FFA4 or GPR120) has appeared as an interesting potential target for the treatment of metabolic disorders. At present, most FFA4 ligands are carboxylic acids that are assumed to mimic the endogenous long-chain fatty acid agonists. Here, we report preliminary structure-activity relationship studies of a previously disclosed nonacidic sulfonamide FFA4 agonist. Mutagenesis studies indicate that the compounds are orthosteric agonists despite the absence of a carboxylate function. The preferred compounds showed full agonist activity on FFA4 and complete selectivity over FFA1, although a significant fraction of these noncarboxylic acids also showed partial antagonistic activity on FFA1. Studies in normal and diet-induced obese (DIO) mice with the preferred compound 34 showed improved glucose tolerance after oral dosing in an oral glucose tolerance test. Chronic dosing of 34 in DIO mice resulted in significantly increased insulin sensitivity and a moderate but significant reduction in bodyweight, effects that were also present in mice lacking FFA1 but absent in mice lacking FFA4.

    Original languageEnglish
    Pages (from-to)8868-8878
    Number of pages11
    JournalJournal of Medicinal Chemistry
    Volume59
    Issue number19
    DOIs
    Publication statusPublished - 13 Oct 2016

    Bibliographical note

    Publisher Copyright:
    © 2016 American Chemical Society.

    Funding

    We thank the Danish Council for Strategic Research (grant 11-116196) and the University of Southern Denmark for financial support. EC is supported by a fellowship from the Lundbeck Foundation.

    FundersFunder number
    Strategiske Forskningsråd11-116196
    Biotechnology and Biological Sciences Research CouncilBB/K019864/1
    Lundbeckfonden
    Syddansk Universitet

      Fingerprint

      Dive into the research topics of 'Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity'. Together they form a unique fingerprint.

      Cite this